XM does not provide services to residents of the United States of America.

ISS recommends Masimo investors elect activist Politan candidates to board



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>ISS recommends Masimo investors elect activist Politan candidates to board</title></head><body>

NEW YORK, July 15 (Reuters) -Institutional Shareholder Services on Monday recommended that Masimo shareholders elect both director candidates proposed byactivist investment firm Politan, arguing change is needed at the medical device maker.

ISS, the proxy advisory firm whose recommendations often influence how investors decide on proposed mergers and who serves on boards, wrote that change is necessary even after Politan won two board seats last year in a vote.

The board will have six members after the July 25 meeting.

Masimo's stock price has fallen 27% in the last 52 weeks and Politan has said it would immediately review strategy, costs and plans for growth if its candidates are elected.

U.S.-basedMasimo MASI.O "has continued to display a dangerous lack of accountability to shareholders that will require additional board change to rectify," the report, seenby Reuters, said.

ISS recommended investors elect Bill Jellison and Darlene Solomon instead of backing Masimo founder and CEO Joe Kiani and Christopher Chavez. Only two board seats will be voted on this year.

While ISS said Kiani deserves credit for shaping the company into a "business with an innovative and successful core product" it wrote that the company was "operating like a private business, and was disregarding shareholders in the process."

Politan has offered to reappoint Kiani to the board if he is ousted and has said it is not actively seeking to replace him as CEO.

ISS said Jellison and Solomon are both independent from Kiani and have appropriate experience serving on public company boards and with mergers and acquisitions and business separations.

ISS' report came on the heels of rival proxy advisory firm Glass Lewis' report, which also recommended voting for both dissident candidates.






Reporting by Svea Herbst-Bayliss; Editing by Rod Nickel

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.